Tropic Biosciences
UK agricultural biotech company using CRISPR gene editing and proprietary GEiGS technology to develop disease-resistant, climate-resilient tropical crops including bananas, coffee, and rice.
Overview
Tropic Biosciences is a Norwich-based agricultural biotechnology company applying cutting-edge genetic innovation to tropical agriculture. Using CRISPR gene editing combined with its proprietary GEiGS (Gene Editing induced Gene Silencing) platform, Tropic develops crop varieties with improved disease resistance, reduced pesticide dependency, and enhanced climate resilience. The company focuses on staple tropical crops — bananas, coffee, and rice — that are critical to global food security but increasingly threatened by climate change and disease. Tropic's banana program addresses Panama disease (Tropical Race 4), a devastating fungal pathogen that threatens global banana production. The company's gene-edited varieties aim to provide durable resistance without relying on chemical treatments, enabling brighter futures for tropical growers worldwide.
Funding History
Tropic Biosciences secures €91.3M Series C to scale gene-edited bananas and climate-resilient crops globally.
Tropic’s €91.3M scales gene-edited bananas that beat Panama disease worldwide
Frequently Asked Questions
- How much has Tropic Biosciences raised in total?
- Tropic Biosciences has raised a total of $196M across 2 funding rounds.
- Who are Tropic Biosciences's investors?
- Tropic Biosciences's investors include Undisclosed.
- What does Tropic Biosciences do?
- Tropic Biosciences is a Norwich-based agricultural biotechnology company applying cutting-edge genetic innovation to tropical agriculture. Using CRISPR gene editing combined with its proprietary GEiGS (Gene Editing induced Gene Silencing) platform, Tropic develops crop varieties with improved disease resistance, reduced pesticide dependency, and enhanced climate resilience. The company focuses on staple tropical crops — bananas, coffee, and rice — that are critical to global food security but increasingly threatened by climate change and disease. Tropic's banana program addresses Panama disease (Tropical Race 4), a devastating fungal pathogen that threatens global banana production. The company's gene-edited varieties aim to provide durable resistance without relying on chemical treatments, enabling brighter futures for tropical growers worldwide.
- Where is Tropic Biosciences headquartered?
- Tropic Biosciences is headquartered in Norwich, United Kingdom.
Investors
Related Insights
A comprehensive analysis of Hebbia's funding history, investors, competitive position, and growth trajectory in the Enterprise AI space.
An in-depth analysis of Lux Capital's AI investment portfolio, strategy, co-investors, and sector focus across 4 tracked deals.
A comprehensive analysis of Mind Robotics's funding history, investors, competitive position, and growth trajectory in the AI space.